Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home versus center-based eculizumab administration in adults with classic PNH
NL-OMON29026Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of eculizumab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Radboud University Medical Center. Primary endpoint: Patient satisfaction. Planned start Nov 2011; status: not yet recruiting.
02
Drugs
eculizumab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NL-OMON29026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29026.